Search Results - "Parolia, Abhijit"

Refine Results
  1. 1

    Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer by Parolia, Abhijit, Cieslik, Marcin, Chu, Shih-Chun, Xiao, Lanbo, Ouchi, Takahiro, Zhang, Yuping, Wang, Xiaoju, Vats, Pankaj, Cao, Xuhong, Pitchiaya, Sethuramasundaram, Su, Fengyun, Wang, Rui, Feng, Felix Y., Wu, Yi-Mi, Lonigro, Robert J., Robinson, Dan R., Chinnaiyan, Arul M.

    Published in Nature (London) (01-07-2019)
    “…Abtract Forkhead box A1 (FOXA1) is a pioneer transcription factor that is essential for the normal development of several endoderm-derived organs, including…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The non-coding transcriptome as a dynamic regulator of cancer metastasis by Crea, Francesco, Clermont, Pier Luc, Parolia, Abhijit, Wang, Yuzhuo, Helgason, Cheryl D.

    Published in Cancer and metastasis reviews (01-03-2014)
    “…Since the discovery of microRNAs, non-coding RNAs (NC-RNAs) have increasingly attracted the attention of cancer investigators. Two classes of NC-RNAs are…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors by Mumphrey, Michael B., Hosseini, Noshad, Parolia, Abhijit, Geng, Jie, Zou, Weiping, Raghavan, Malini, Chinnaiyan, Arul, Cieslik, Marcin

    Published in Cell reports (Cambridge) (29-08-2023)
    “…Disruption of antigen presentation via loss of major histocompatibility complex (MHC) expression is a strategy whereby cancer cells escape immune surveillance…”
    Get full text
    Journal Article
  6. 6
  7. 7

    miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer by Nabavi, Noushin, Saidy, Nur Ridzwan Nur, Venalainen, Erik, Haegert, Anne, Parolia, Abhijit, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Dong, Xin, Collins, Colin, Crea, Francesco, Wang, Yuzhuo

    Published in Scientific reports (22-06-2017)
    “…Carcinoma of the prostate is the most common cancer in men. Treatment of aggressive prostate cancer involves a regiment of radical prostectomy, radiation…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo by Parolia, Abhijit, Crea, Francesco, Xue, Hui, Wang, Yuwei, Mo, Fan, Ramnarine, Varune Rohan, Liu, Hui Hsuan, Lin, Dong, Saidy, Nur Ridzwan Nur, Clermont, Pier-Luc, Cheng, Hongwei, Collins, Colin, Wang, Yuzhuo, Helgason, Cheryl D

    Published in Molecular cancer (21-02-2015)
    “…Long non-coding RNAs (lncRNAs) can orchestrate oncogenic or tumor-suppressive functions in cancer biology. Accordingly, PCGEM1 and PRNCR1 were implicated in…”
    Get full text
    Journal Article
  10. 10

    The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program by Parolia, Abhijit, Venalainen, Erik, Xue, Hui, Mather, Rebecca, Lin, Dong, Wu, Rebecca, Pucci, Perla, Rogalski, Jason, Evans, Joseph R., Feng, Felix, Collins, Colin C., Wang, Yuzhuo, Crea, Francesco

    Published in Molecular oncology (01-05-2019)
    “…Prostate cancer (PCa) is driven by the androgen receptor (AR)‐signaling axis. Hormonal therapy often mitigates PCa progression, but a notable number of cases…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer by Clermont, Pier-Luc, Crea, Francesco, Chiang, Yan Ting, Lin, Dong, Zhang, Amy, Wang, James Z L, Parolia, Abhijit, Wu, Rebecca, Xue, Hui, Wang, Yuwei, Ding, Jiarui, Thu, Kelsie L, Lam, Wan L, Shah, Sohrab P, Collins, Colin C, Wang, Yuzhuo, Helgason, Cheryl D

    Published in Clinical epigenetics (12-02-2016)
    “…While localized prostate cancer (PCa) can be effectively cured, metastatic disease inevitably progresses to a lethal state called castration-resistant prostate…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Non-invasive metabolic imaging of brain tumours in the era of precision medicine by Kim, Michelle M., Parolia, Abhijit, Dunphy, Mark P., Venneti, Sriram

    Published in Nature reviews. Clinical oncology (01-12-2016)
    “…Key Points Brain tumours, such as gliomas, in adults and children are morphologically similar, but harbour different genomic alterations, both across and…”
    Get full text
    Journal Article
  16. 16

    Abstract 4420: Polytect, a robust algorithm to detect somatic mutations in polymorphic MHC/HLA genes by Mumphrey, Michael Brodie, Parolia, Abhijit, Kumar-Sinha, Chandan, Cieslik, Marcin

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Background: The immune system is able to recognize tumor cells through the presentation of mutant peptides via the major histocompatibility complex…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Abstract 3347: Exploring the role of ASXL family of genes in enabling oncogenic AR-signaling in prostate cancer by Parolia, Abhijit, Cao, Xuhong, Chinnaiyan, Arul

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Prostate cancer (PCa) is the second leading cause of cancer-related mortality in North American men. In recent years, there has been mounting evidence…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader by Liu, Lianchao, Parolia, Abhijit, Liu, Yihan, Hou, Caiyun, He, Tongchen, Qiao, Yuanyuan, Eyunni, Sanjana, Luo, Jie, Li, Chungen, Wang, Yongxing, Zhou, Fengtao, Huang, Weixue, Ren, Xiaomei, Wang, Zhen, Chinnaiyan, Arul M., Ding, Ke

    Published in Journal of medicinal chemistry (09-05-2024)
    “…Nuclear receptor-binding SET domain-containing 2 (NSD2), a methyltransferase that primarily installs the dimethyl mark on lysine 36 of histone 3 (H3K36me2),…”
    Get full text
    Journal Article